The SiroSkin study: A multi-centre randomised double-blind placebo- controlled trial of 1% topical sirolimus in the chemoprevention of facial squamous cell carcinomas in solid organ transplant recipients

  • Khosrotehrani, Kiarash (Primary Chief Investigator (PCI))
  • Campbell, Scott Bryan (Chief Investigator (CI))
  • Chambers, Daniel (Chief Investigator (CI))
  • Gordon, Louisa (Chief Investigator (CI))
  • Webster, Angela Claire (Chief Investigator (CI))
  • Mar, Victoria (Chief Investigator (CI))
  • Damian, Diona (Chief Investigator (CI))
  • Chong, Alvin Heong (Chief Investigator (CI))
  • Schaider, Helmut (Chief Investigator (CI))
  • Isbel, Nicole Maree (Chief Investigator (CI))
  • McKenzie, Scott (Associate Investigator (AI))
  • Gin, Douglas (Associate Investigator (AI))
  • Soyer, Peter (Associate Investigator (AI))

Project: Research

Project Details

StatusActive
Effective start/end date1/02/22 → 31/01/27